RecruitingNCT07312266

Questioning the Epidemiology of Asymptomatic TB


Sponsor

Barcelona Institute for Global Health

Enrollment

6,770 participants

Start Date

Aug 11, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Tuberculosis (TB) remains one of the world's leading causes of morbidity and mortality. Current TB control strategies focus largely on the binary paradigm of TB, which tackle Mtb infection and the symptomatic stages of the disease as the major drivers of the TB epidemic. However, prevalence surveys have shown that about 50% of cases in which Mycobacterium tuberculosis is isolated from sputum but do not report having symptoms. Therefore, asymptomatic TB may play an important role in TB transmission. However, no field study has demonstrated direct transmission from a subclinical TB case to a confirmed secondary case. TB-QUEST is an ERC-funded epidemiological field study that aims to provide direct evidence of effective transmission from asymptomatic TB cases to their close contacts using advanced genomic methods, and to better characterize the asymptomatic stage of TB within the natural history of disease.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines asymptomatic tuberculosis (TB) — TB infection in people who have no symptoms — specifically among people living with HIV. It investigates how common TB is without symptoms and how best to detect it, with a focus on people who are newly on HIV treatment and not yet virally suppressed. **You may be eligible if...** - You are 18 or older - You have a confirmed HIV diagnosis - You attend a health facility for routine HIV care - For a sub-study: you have been on HIV treatment (ART) for less than 6 months, your virus is not yet suppressed, you have a CD4 count above 350, and you have a TB-suggestive chest X-ray but no fever or cough **You may NOT be eligible if...** - You have been treated for TB in the past 12 months - You are pregnant - You are unwilling to undergo required procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Centro de Investigação em Saúde de Manhiça (CISM)

Manhiça, Maputo Province, Mozambique

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07312266


Related Trials